These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 33514365)

  • 1. Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study.
    Lin A; Wong ND; Razipour A; McElhinney PA; Commandeur F; Cadet SJ; Gransar H; Chen X; Cantu S; Miller RJH; Nerlekar N; Wong DTL; Slomka PJ; Rozanski A; Tamarappoo BK; Berman DS; Dey D
    Cardiovasc Diabetol; 2021 Jan; 20(1):27. PubMed ID: 33514365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Learning-Based Quantification of Epicardial Adipose Tissue Volume and Attenuation Predicts Major Adverse Cardiovascular Events in Asymptomatic Subjects.
    Eisenberg E; McElhinney PA; Commandeur F; Chen X; Cadet S; Goeller M; Razipour A; Gransar H; Cantu S; Miller RJH; Slomka PJ; Wong ND; Rozanski A; Achenbach S; Tamarappoo BK; Berman DS; Dey D
    Circ Cardiovasc Imaging; 2020 Feb; 13(2):e009829. PubMed ID: 32063057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning to predict the long-term risk of myocardial infarction and cardiac death based on clinical risk, coronary calcium, and epicardial adipose tissue: a prospective study.
    Commandeur F; Slomka PJ; Goeller M; Chen X; Cadet S; Razipour A; McElhinney P; Gransar H; Cantu S; Miller RJH; Rozanski A; Achenbach S; Tamarappoo BK; Berman DS; Dey D
    Cardiovasc Res; 2020 Dec; 116(14):2216-2225. PubMed ID: 31853543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects.
    Goeller M; Achenbach S; Marwan M; Doris MK; Cadet S; Commandeur F; Chen X; Slomka PJ; Gransar H; Cao JJ; Wong ND; Albrecht MH; Rozanski A; Tamarappoo BK; Berman DS; Dey D
    J Cardiovasc Comput Tomogr; 2018; 12(1):67-73. PubMed ID: 29233634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DEep LearnIng-based QuaNtification of epicardial adipose tissue predicts MACE in patients undergoing stress CMR.
    Guglielmo M; Penso M; Carerj ML; Giacari CM; Volpe A; Fusini L; Baggiano A; Mushtaq S; Annoni A; Cannata F; Cilia F; Del Torto A; Fazzari F; Formenti A; Frappampina A; Gripari P; Junod D; Mancini ME; Mantegazza V; Maragna R; Marchetti F; Mastroiacovo G; Pirola S; Tassetti L; Baessato F; Corino V; Guaricci AI; Rabbat MG; Rossi A; Rovera C; Costantini P; van der Bilt I; van der Harst P; Fontana M; Caiani EG; Pepi M; Pontone G
    Atherosclerosis; 2024 Oct; 397():117549. PubMed ID: 38679562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoronary Measures Enhance the Predictive Value of Cardiac CT Above Traditional Risk Factors and CAC Score in the General Population.
    Mahabadi AA; Lehmann N; Möhlenkamp S; Pundt N; Dykun I; Roggenbuck U; Moebus S; Jöckel KH; Erbel R; Kälsch H;
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1177-1185. PubMed ID: 27450878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial adipose tissue volume and coronary calcification among people living with diabetes: a cross-sectional study.
    Cosson E; Nguyen MT; Rezgani I; Tatulashvili S; Sal M; Berkane N; Allard L; Brillet PY; Bihan H
    Cardiovasc Diabetol; 2021 Feb; 20(1):35. PubMed ID: 33546697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fully automated epicardial adipose tissue volume quantification with deep learning and relationship with CAC score and micro/macrovascular complications in people living with type 2 diabetes: the multicenter EPIDIAB study.
    Gaborit B; Julla JB; Fournel J; Ancel P; Soghomonian A; Deprade C; Lasbleiz A; Houssays M; Ghattas B; Gascon P; Righini M; Matonti F; Venteclef N; Potier L; Gautier JF; Resseguier N; Bartoli A; Mourre F; Darmon P; Jacquier A; Dutour A
    Cardiovasc Diabetol; 2024 Sep; 23(1):328. PubMed ID: 39227844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome.
    Cho KI; Jo EA; Cho SH; Kim BH
    Metab Syndr Relat Disord; 2017 Jun; 15(5):226-232. PubMed ID: 28346857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicardial adipose tissue volume but not density is an independent predictor for myocardial ischemia.
    Hell MM; Ding X; Rubeaux M; Slomka P; Gransar H; Terzopoulos D; Hayes S; Marwan M; Achenbach S; Berman DS; Dey D
    J Cardiovasc Comput Tomogr; 2016; 10(2):141-9. PubMed ID: 26817413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning integration of circulating and imaging biomarkers for explainable patient-specific prediction of cardiac events: A prospective study.
    Tamarappoo BK; Lin A; Commandeur F; McElhinney PA; Cadet S; Goeller M; Razipour A; Chen X; Gransar H; Cantu S; Miller RJ; Achenbach S; Friedman J; Hayes S; Thomson L; Wong ND; Rozanski A; Slomka PJ; Berman DS; Dey D
    Atherosclerosis; 2021 Feb; 318():76-82. PubMed ID: 33239189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis.
    Malik S; Zhao Y; Budoff M; Nasir K; Blumenthal RS; Bertoni AG; Wong ND
    JAMA Cardiol; 2017 Dec; 2(12):1332-1340. PubMed ID: 29117273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicardial adipose tissue volume and myocardial ischemia in asymptomatic people living with diabetes: a cross-sectional study.
    Cosson E; Nguyen MT; Rezgani I; Berkane N; Pinto S; Bihan H; Tatulashvili S; Taher M; Sal M; Soussan M; Brillet PY; Valensi P
    Cardiovasc Diabetol; 2021 Nov; 20(1):224. PubMed ID: 34819079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis.
    Yerramasu A; Dey D; Venuraju S; Anand DV; Atwal S; Corder R; Berman DS; Lahiri A
    Atherosclerosis; 2012 Jan; 220(1):223-30. PubMed ID: 22015177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf recall study.
    Mahabadi AA; Lehmann N; Kälsch H; Robens T; Bauer M; Dykun I; Budde T; Moebus S; Jöckel KH; Erbel R; Möhlenkamp S
    JACC Cardiovasc Imaging; 2014 Sep; 7(9):909-16. PubMed ID: 25190138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Non-alcoholic Fatty Liver Disease and RCA Pericoronary Adipose Tissue CT Attenuation in Patients with Acute Chest Pain.
    Yang W; Wen D; Li S; Zhao H; Xu J; Liu J; Chang Y; Xu J; Zheng M
    Acad Radiol; 2024 May; 31(5):1773-1783. PubMed ID: 38160090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification.
    Cho YK; Kang YM; Yoo JH; Lee J; Lee SE; Yang DH; Kang JW; Park JY; Jung CH; Kim HK; Lee WJ
    Sci Rep; 2018 Aug; 8(1):12004. PubMed ID: 30104707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease.
    Nishihara T; Miyoshi T; Nakashima M; Miki T; Toda H; Yoshida M; Ichikawa K; Osawa K; Yuasa S
    Cardiovasc Diabetol; 2024 May; 23(1):167. PubMed ID: 38730426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of epicardial adipose tissue predicts major adverse cerebral and cardiovascular events following transcatheter aortic valve implantation.
    Sato T; Yufu K; Yamasaki H; Harada T; Yamauchi S; Ishii Y; Fukuda T; Kawashima T; Shuto T; Akioka H; Shinohara T; Teshima Y; Wada T; Miyamoto S; Takahashi N
    Heart Vessels; 2024 Jul; 39(7):646-653. PubMed ID: 38502318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.